What is Cardene (nicardipine) in 4.8% dextrose, and what does “in a plastic container” mean?
Cardene is the brand name for nicardipine, an IV calcium channel blocker used to treat certain types of high blood pressure (hypertensive emergencies). When labeled as “in 4.8% dextrose,” the medication is supplied in an IV solution where dextrose (a form of sugar) is the carrier fluid.
The phrase “plastic container” indicates the IV dosage form is packaged in a plastic infusion container rather than glass. This packaging detail matters for storage/handling and may affect compatibility with IV administration sets and other drugs, but it does not change the active ingredient (nicardipine).
Is this the same as Cardene IV in normal saline?
Usually not. Nicardipine IV products can be supplied in different diluents (for example, saline vs. dextrose-containing solutions). The “4.8% dextrose” label specifically tells you the carrier is dextrose in water, not saline. That can matter for:
- Patients who need to limit dextrose/glucose intake
- Compatibility with other IV medications or fluids being co-administered through the same line
Why would a hospital use a dextrose (4.8%) formulation instead of saline?
Hospitals may choose the specific marketed formulation they stock and that matches their IV protocol, because nicardipine dosing and infusion setup depend on the available product. Clinically, selecting dextrose vs saline can also be relevant for patients with glucose management needs (for example, diabetes or fluid/glucose restrictions), though the exact practice depends on institutional policy.
What do clinicians typically check before giving nicardipine IV in dextrose?
Common practical checks include:
- The exact product labeling (nicardipine concentration and diluent)
- Total fluid/glucose contribution from the dextrose carrier
- Compatibility with the planned infusion method and other concurrent IV drugs
Is “4.8% dextrose in plastic container” a specific commercial product?
Yes. That wording matches how IV drugs are described in pharmacy and product labeling: it identifies the concentration of nicardipine and the diluent system (4.8% dextrose) plus the container type (plastic).
If you’re asking for dosing or how to administer it
Dose and administration details for nicardipine depend on the indication, patient factors, and the exact concentration on the vial/bag label. If you can share the strength (for example, how many mg per mL or per bag) or upload the label text you have, I can help interpret what the packaging description means for preparation and administration.
Sources
No external sources were provided in the prompt, and I don’t have the exact Cardene product label details you’re looking at. If you share the label concentration (mg/mL) or a photo/text of the “Drug Facts” section, I can respond more precisely.